Skip Navigation

Link to  the National Institutes of Health NIDA NEWS NIDA News RSS Feed
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Keep Your Body Healthy
Go to the Home pageGo to the About Nida pageGo to the News pageGo to the Meetings & Events pageGo to the Funding pageGo to the Publications page
PhysiciansResearchersParents/TeachersStudents/Young AdultsEn Español Drugs of Abuse & Related Topics
NIDA Home > NIDA Science & Practice Perspectives

NIDA Science & Practice Perspectives

Volume 2, Number 1 - September 2003

Reference Article Abstracts

Integrating Substance Abuse Treatment and Criminal Justice Supervision [pdf - 248K]
Douglas B. Marlowe, J.D., Ph.D.

Cornish, J.W., et al., 1997. Naltrexone pharmacotherapy for opioid dependent federal probationers. Journal of Substance Abuse Treatment 14:529-534. Abstract Available

Festinger, D.S., et al., 2002. Status hearings in drug court: When more is less and less is more. Drug and Alcohol Dependence 68(2):151-157. Abstract Available

General Accounting Office, 2002. Drug Courts: Better DOJ Data Collection and Evaluation Efforts Needed To Measure Impact of Drug Court Programs. Publication No. GAO-02-434. Washington, DC: GAO. Full Text Available [pdf]

Gottfredson, D.C.; Najaka, S.S.; and Kearley, B., 2003. Effectiveness of drug courts: Evidence from a randomized trial. Criminology & Public Policy 2(2). Abstract Available

Marlowe, D.B., et al., 2003b. Are judicial status hearings a "key component" of drug court? During-treatment data from a randomized trial. Criminal Justice & Behavior 30:141-162. Full Text Available

McLellan, A.T., et al., 2000. Drug dependence, a chronic medical illness: Implications for treatment, insurance, and outcomes evaluation. Journal of the American Medical Association 284(13):1689-1695. Abstract Available

National Institute of Justice, 1999. Annual Report on Drug Use Among Adult and Juvenile Arrestees. Washington, DC: U.S. Department of Justice. Clinical Psychology Review 12:93-116. Full Text Available [pdf]

Simpson, D.D.; Joe, G.W.; and Brown, B.S., 1997. Treatment retention and follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychology of Addictive Behaviors 11(4):294-307. Abstract Available


Treating Adolescents for Substance Abuse and Comorbid Psychiatric Disorders
Paula D. Riggs, M.D.

Deas, D., and Thomas, S.E., 2001. An overview of controlled studies of adolescent substance abuse treatment. American Journal on Addictions 10(2):178-189. Abstract Available

Kaminer, Y., et al., 1998. Psychotherapies for adolescent substance abusers: A pilot study. Journal of Nervous and Mental Disease 186(11):684-690. Abstract Available

Michelson, D., et al., 2002. Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: A randomized, placebo-controlled study. American Journal of Psychiatry 159(11):1896-1901. Abstract Available

Riggs, P.D., 1997. Fluoxetine in drug-dependent delinquents with major depression: An open trial. Journal of Child and Adolescent Psychopharmacology 7(2):87-95. Abstract Available

Riggs, P.D., et al., 1998. An open trial of bupropion for ADHD in adolescents with substance use disorders and conduct disorder. Journal of the American Academy of Child and Adolescent Psychiatry 37(12):1271-1278. Abstract Available

Rotheram-Borus, M.J., and Duan, N., 2003. Next generation of preventive interventions. Journal of the American Academy of Child and Adolescent Psychiatry 42(5):518-526. Abstract Available

Safer, D.J.; Zito, J.M.; and Gardner, J.F., 2001. Pemoline hepatotoxicity and postmarketing surveillance. Journal of the American Academy of Child and Adolescent Psychiatry 40(6):622-629. Abstract Available

Solhkhah, R., and Wilens, T.E., 1998. Pharmacotherapy of adolescent AOD use disorders. Alcohol Health & Research World 22(2):122-126. Full Text Available [pdf]

Tarter, R.E., 2002. Etiology of adolescent substance abuse: A developmental perspective. American Journal on Addictions 11(3):171-191. Abstract Available

Teplin, L.A., et al., 2002. Psychiatric disorders in youth in juvenile detention. Archives of General Psychiatry 59(12):1133-1143. Abstract Available

Tims, F.M., et al., 2002. Characteristics and problems of 600 adolescent cannabis abusers in outpatient treatment. Addiction 97(suppl 1):46-57. Full Text Available

Wagner, E.F., et al., 1999. Innovations in adolescent substance abuse intervention. Alcoholism, Clinical and Experimental Research 23(2):236-249. Abstract Available

Weinberg, N.Z., et al., 1998. Adolescent substance abuse: A review of the past 10 years. Journal of the American Academy of Child and Adolescent Psychiatry 37(3):252-261. Abstract Available

Wilens, T.E.; Biederman, J.; and Spencer, T.J., 1997. Case study: Adverse effects of smoking marijuana while receiving tricyclic antidepressants. Journal of the American Academy of Child and Adolescent Psychiatry 36(1):45-48. Abstract Available

Wilens, T.E., et al., 2001. A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults. American Journal of Psychiatry 158(2):282-288. Abstract Available

Wise, B.K.; Cuffe, S.P.; and Fischer, T., 2001. Dual diagnosis and successful participation of adolescents in substance abuse treatment. Journal of Substance Abuse Treatment 21(3):161-165. Abstract Available


Targeting Nicotine Addiction in a Substance Abuse Program
James R. Sharp, Ph.D., Steven Schwartz, Ph.D. (Cand.) CASAC, Thomas Nightingale, B.S.,CASAC, and Steven Novak, M.D.

Dale, L.C., et al., 1995. High-dose nicotine patch therapy: Percentage of replacement and smoking cessation. Journal of the American Medical Association 274(17):1353-1358. Abstract Available

Frosch, D.L., et al., 2000. Associations between tobacco smoking and illicit drug use among methadone-maintained opiate-dependent individuals. Experimental and Clinical Psychopharmacology 8(1):97-103. Abstract Available

Kornitzer, M., et al., 1995. Combined use of nicotine patch and gum in smoking cessation: A placebo-controlled clinical trial. Prevention Medicine 24(1):41-47. Abstract Available

Patten, C.A.; Martin, J.E.; and Owen, N., 1996. Can psychiatric and chemical dependency treatment units be smoke free? Journal of Substance Abuse Treatment 13(2):107-118. Abstract Available

Taylor, R.C., et al., 2000. Tobacco craving: Intensity-related effects of imagery scripts in drug abusers. Experimental and Clinical Psychopharmacology 8(1):75-87. Abstract Available


12-Step Participation as a Pathway to Recovery: The Maryhaven Experience and Implications for Treatment and Research
Gregory S. Brigham, Ph.D.

Humphreys, K., 1999. Professional interventions that facilitate 12-step self-help group involvement. Alcohol Research & Health 23(2):93-98. Abstract Available

Kingree, J.B.; Sullivan, B.F.; and Thompson, M.P., 1999. Attributions for the development of substance addiction among participants in a 12-step oriented treatment program. Journal of Psychoactive Drugs 31(2):129-135. Abstract Available

McCrady, B.S., 1994. Alcoholics Anonymous and behavior therapy: Can habits be treated as diseases? Can diseases be treated as habits? Journal of Consulting and Clinical Psychology 62(6):1159-1166. Abstract Available

Morgenstern, J., et al., 1996. Modeling therapeutic response to 12-step treatment: Optimal responders, nonresponders, and partial responders. Journal of Substance Abuse Treatment 8(1):45-59. Abstract Available

Room, R., and Greenfield, T., 1993. Alcoholics Anonymous, other 12-step movements and psychotherapy in the US population, 1990. Addiction 88(4):555-562. Abstract Available

Sisson, R.W., and Mullams, J.H., 1981. The use of systematic encouragement and community access procedures to increase attendance at Alcoholics Anonymous and Al-Anon meetings. American Journal of Drug and Alcohol Abuse 8(3):371-376. Abstract Available

Steigerwald, F., and Stone, D., 1999. Cognitive restructuring and the 12-step program of Alcoholics Anonymous. Journal of Substance Abuse Treatment 16(4):321-327. Abstract Available

Tonigan, J.S.; Ashcroft, F.; and Miller, W.R., 1995. AA group dynamics and 12-step activity. Journal of Studies on Alcohol 56(6):616-621. Abstract Available

Weiss, R.G., et al., 2000. Predictors of self-help group attendance in cocaine dependent patients. Journal of Studies on Alcohol 61(5):714-719. Abstract Available


Response: The Marriage of Drug Abuse Treatment and 12-step Strategies
Robert F. Forman, Ph.D., Keith Humphreys, Ph.D., J. Scott Tonigan, Ph.D.

Laudet, A.B., et al., 2000. Addictions services: Support, mutual aid and recovery from dual diagnosis. Community Mental Health Journal 36(5):457-476. Abstract Available

Rychtarik, R.G., et al., 2000. Alcoholics Anonymous and the use of medications to prevent relapse: An anonymous survey of member attitudes. Journal of Studies on Alcohol 61(1):134-138. Abstract Available

Weiss, R.D., et al., 2000. Predictors of self-help group attendance in cocaine-dependent patients. Journal of Studies on Alcohol 61(5):714-719. Abstract Available

Weiss, R.D., et al., 1996. Self-help activities in cocaine-dependent patients entering treatment: Results from the NIDA collaborative cocaine treatment study. Drug and Alcohol Dependence 43(1-2):79-86. Abstract Available



- Issue Index
- Subscribe to the Journal
- Information for Authors
- Conflict of Interest Policy
- Journal Staff

Get Adobe Reader

NIDA Addiction Science & Clinical Practice
Subscription Department
MasiMax Resources, Inc.
1375 Piccard Drive, Suite 175
Rockville, MD 20850

Fax: (240) 632–0519

Email: nida-ascp@masimax.com



NIDA Home | Site Map | Search | FAQs | Accessibility | Privacy | FOIA (NIH) | Employment | Print Version


National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. Last updated on Wednesday, June 11, 2008. The U.S. government's official web portal